Apr. 21 at 8:12 PM
$BBNX Q1 '26 Earnings Results & Recap
• Reported GAAP EPS of -
$0.49 up 47.31% YoY
• Reported revenue of
$27.63M up 56.62% YoY
• Beta Bionics raised its full year 2026 guidance, now expecting total revenue of
$131M to
$136M, gross margin of 57.5% to 59.5%, and 37% to 39% of new patient starts reimbursed through the PBP channel.
